antipyrine has been researched along with melphalan in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Gutsche, W; Jungstand, W; Werner, W; Wohlrabe, K | 1 |
Noker, PE; Simpson-Herren, L | 1 |
Collins, FG; Skibba, JL | 1 |
7 other study(ies) available for antipyrine and melphalan
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[The synthesis and carcinostatic effect of 4-[bis-(2-chloroethyl)-amino]-2, 3-dimethyl-1-phenyl-5-pyrazolone ("imet 3995")].
Topics: Ampyrone; Animals; Antineoplastic Agents; Antipyrine; Carcinoma 256, Walker; Drug Evaluation, Preclinical; Female; Lethal Dose 50; Leukemia, Experimental; Male; Melphalan; Mice; Nitrogen Mustard Compounds; Rats; Sarcoma 180 | 1975 |
Diversity of penetration of anti-cancer agents into solid tumours.
Topics: Adenocarcinoma; Alkylating Agents; Animals; Antineoplastic Agents; Antipyrine; Biological Transport; Breast Neoplasms; Carbon Radioisotopes; Cell Line; Dose-Response Relationship, Drug; Female; Humans; Kinetics; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Transplantation, Heterologous | 1991 |
Altered hepatic functions and microsomal activity in perfused rat liver by hyperthermia combined with alkylating agents.
Topics: Alkylating Agents; Animals; Antipyrine; Biotransformation; Cyclophosphamide; Gluconeogenesis; Liver; Male; Mechlorethamine; Melphalan; Microsomes, Liver; Oxygen Consumption; Rats; Urea | 1983 |